| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | PFIZER INC | 600,000 | 20,874,000 | 8.78% | ||
| 2 | Esperion Therapeutics Inc | 200,000 | 18,520,000 | 7.79% | ||
| 3 | CELGENE CORP | 110,000 | 12,681,000 | 5.33% | ||
| 4 | ULTRAGENYX PHARMACEUTICAL INC COM | 175,000 | 10,866,000 | 4.57% | ||
| 5 | GILEAD SCIENCES INC | 100,000 | 9,813,000 | 4.13% | ||
| 6 | ALLERGAN PLC | 25,000 | 7,441,000 | 3.13% | ||
| 7 | ACCELERON PHARMA | 175,000 | 6,661,000 | 2.80% | ||
| 8 | ISHARES TR | 50,000 | 6,219,000 | 2.62% | ||
| 9 | SUPERNUS PHARMACEUTICALS INC COM | 500,000 | 6,045,000 | 2.54% | ||
| 10 | PUMA BIOTECHNOLOGY | 25,000 | 5,903,000 | 2.48% | ||
| 11 | ZIMMER BIOMET HLDGS INC | 50,000 | 5,876,000 | 2.47% | ||
| 12 | ACCELERATE DIAGNOSTICS INC | 250,000 | 5,625,000 | 2.37% | ||
| 13 | ENDO INTL | 60,000 | 5,382,000 | 2.26% | ||
| 14 | HUMANA | 30,000 | 5,341,000 | 2.25% | ||
| 15 | EXPRESS SCRIPTS HLDG CO | 60,000 | 5,206,000 | 2.19% | ||
| 16 | HORIZON PHARMA PLC | 200,000 | 5,194,000 | 2.18% | ||
| 17 | ST JUDE | 75,000 | 4,905,000 | 2.06% | ||
| 18 | GW PHARMACEUTICALS PLC | 50,000 | 4,557,000 | 1.92% | ||
| 19 | WELLCARE HEALTH PLANS INC COM | 45,000 | 4,116,000 | 1.73% | ||
| 20 | WRIGHT MEDICAL GROUP N.V. | 150,000 | 3,933,000 | 1.65% | ||
| 21 | CIGNA CORPORATION | 30,000 | 3,883,000 | 1.63% | ||
| 22 | AERIE PHARMACEUTICALS INC | 120,000 | 3,761,000 | 1.58% | ||
| 23 | CARDINAL HEALTH INC | 40,000 | 3,611,000 | 1.52% | ||
| 24 | IMPAX LABORATORIES INC | 75,000 | 3,515,000 | 1.48% | ||
| 25 | CymaBay Therapeutics | 500,000 | 3,460,000 | 1.46% | ||
| 26 | NOVADAQ TECHNOLOGIES INC | 200,000 | 3,248,000 | 1.37% | ||
| 27 | MEDIVATION INC | 25,000 | 3,227,000 | 1.36% | ||
| 28 | ARATANA THERAPEUTICS INC COM | 200,000 | 3,202,000 | 1.35% | ||
| 29 | ANTHEM INC | 20,000 | 3,088,000 | 1.30% | ||
| 30 | MERCK & CO INC | 50,000 | 2,874,000 | 1.21% | ||
| 31 | CELLDEX THERAPEUTICS INC NEW | 100,000 | 2,787,000 | 1.17% | ||
| 32 | TETRAPHASE PHARMACEUTICALS I COM | 75,000 | 2,748,000 | 1.16% | ||
| 33 | LIGAND PHARMACEUTICALS INC | 35,000 | 2,699,000 | 1.14% | ||
| 34 | WRIGHT MEDICAL GROUP NV | 100,000 | 2,580,000 | 1.09% | ||
| 35 | DYAX CORP | 150,000 | 2,513,000 | 1.06% | ||
| 36 | ABBOTT LABS | 50,000 | 2,317,000 | 0.97% | ||
| 37 | ABBVIE INC | 50,000 | 2,317,000 | 0.97% | ||
| 38 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 125,000 | 2,248,000 | 0.95% | ||
| 39 | HCP INC | 50,000 | 2,161,000 | 0.91% | ||
| 40 | IMMUNE DESIGN CORP COM | 100,000 | 2,111,000 | 0.89% | ||
| 41 | NEUROCRINE BIOSCIE COM USD0.001 | 50,000 | 1,986,000 | 0.84% | ||
| 42 | ASSEMBLY BIOSCIENCES INC | 150,000 | 1,986,000 | 0.84% | ||
| 43 | SPECTRANETICS CORP | 50,000 | 1,738,000 | 0.73% | ||
| 44 | IPC THE HOSPITALIST CO | 35,000 | 1,632,000 | 0.69% | ||
| 45 | CASTLIGHT HEALTH INC COM CL B | 200,000 | 1,552,000 | 0.65% | ||
| 46 | PTC THERAPEUTICS INC | 25,000 | 1,521,000 | 0.64% | ||
| 47 | ENTEROMEDICS INC | 1,444,000 | 1,321,000 | 0.56% | ||
| 48 | DERMIRA INC | 80,000 | 1,228,000 | 0.52% | ||
| 49 | THERAPEUTICSMD INC | 200,000 | 1,210,000 | 0.51% | ||
| 50 | KINDRED HEALTHCARE INC | 50,000 | 1,190,000 | 0.50% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001597549-15-000011, filed 2015.06.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
